14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $27.14 $33.02 Wednesday, 24th Apr 2024 AGIO stock ended at $31.67. This is 0.440% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 3.00% from a day low at $31.32 to a day high of $32.26.
90 days $21.66 $35.48
52 weeks $19.80 $35.48

Historical Agios Pharmaceuticals prices

Date Open High Low Close Volume
Feb 18, 2021 $51.38 $51.96 $49.89 $50.34 594 969
Feb 17, 2021 $54.37 $54.37 $51.61 $52.50 720 199
Feb 16, 2021 $55.38 $55.89 $53.82 $54.37 727 985
Feb 12, 2021 $57.63 $58.25 $55.69 $55.89 631 186
Feb 11, 2021 $57.32 $58.93 $55.43 $57.50 658 551
Feb 10, 2021 $55.14 $58.19 $53.83 $56.68 1 454 585
Feb 09, 2021 $55.20 $57.22 $54.22 $55.01 712 422
Feb 08, 2021 $52.94 $56.08 $52.64 $55.82 837 639
Feb 05, 2021 $50.94 $53.39 $50.36 $52.84 450 372
Feb 04, 2021 $51.53 $51.53 $50.04 $50.49 391 880
Feb 03, 2021 $50.50 $52.48 $50.50 $51.25 433 114
Feb 02, 2021 $49.05 $50.98 $49.00 $50.70 677 100
Feb 01, 2021 $47.50 $49.12 $47.25 $48.79 460 305
Jan 29, 2021 $45.88 $48.21 $45.45 $46.97 698 203
Jan 28, 2021 $46.25 $46.54 $44.79 $45.44 630 923
Jan 27, 2021 $48.34 $48.57 $45.76 $45.84 775 747
Jan 26, 2021 $49.61 $50.25 $47.89 $48.04 552 144
Jan 25, 2021 $47.86 $49.75 $47.02 $49.50 827 020
Jan 22, 2021 $47.02 $47.95 $46.33 $47.47 549 981
Jan 21, 2021 $46.22 $47.99 $44.78 $47.75 1 275 672
Jan 20, 2021 $46.99 $48.29 $45.82 $45.96 558 561
Jan 19, 2021 $46.21 $47.14 $45.68 $46.55 1 324 459
Jan 15, 2021 $45.99 $46.50 $44.26 $45.67 1 433 452
Jan 14, 2021 $47.42 $47.42 $45.79 $45.95 591 629
Jan 13, 2021 $46.40 $48.01 $46.31 $46.50 1 114 930
Click to get the best stock tips daily for free!

About Agios Pharmaceuticals

Agios Pharmaceuticals Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Ph... AGIO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT